Filing Details

Accession Number:
0001209191-13-024897
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-08 16:36:41
Reporting Period:
2013-05-06
Filing Date:
2013-05-08
Accepted Time:
2013-05-08 16:36:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
742112 Invacare Corp IVC Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 952680965
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
937769 Ii B Joseph Richey One Invacare Way
Elyria OH 44035
Senior Vice President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-05-06 1,000 $13.74 662,340 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Class B Common Shares 360,262 Direct
Common Shares 9,238 Indirect By Invacare Retirement Savings Plan
Common Shares 10,134 Indirect By Charitable Remainder Unitrust
Class B Common Shares 16,000 Indirect IRA
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Employee Stock Option (Right to Buy) $0.00 160,500 160,500 Direct
Common Shares Phantom Stock $0.00 353 353 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
160,500 160,500 Direct
353 353 Direct
Footnotes
  1. Owned by the Trustee for the Invacare Retirement Savings Plan. The information given is based on a Plan Statement of December 31, 2012, the most recent information reasonably available.
  2. No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
  3. The reporting person holds previously reported options to buy 160,500 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between August 20, 2003 and March 18, 2013, at exercise prices between $13.37 to $44.30 per share, will expire between August 20, 2013 and March 18, 2023 and became or will become exercisable between September 30, 2004 and March 31, 2017.
  4. Upon cessation of employment in accordance with the terms and conditions of the Invacare Corporation Deferred Compensation Plus Plan.
  5. Owned by Trustee for the Invacare Corporation Deferred Compensation Plus Plan. The information given is based on a Plan Statement of December 31, 2012, the most recent information reasonably available.